Genes · 2015 · 29 citations · 30 references
MedicineGeneticsHematologyEpigeneticsEpigenomicsTranscriptional RegulationAllele-specific Epigenetic RegulationEpigenetic AlterationsMyelodysplastic SyndromesTranscriptional SilencingAberrant Dna MethylationAllele-specific Dna MethylationDna Methylation PatternsHypomethylating AgentsPromoter HypermethylationPromoter MethylationTumor Suppressor Gene HypermethylationTumor Suppressor Gene Methylation
Myelodysplastic syndrome (MDS) is a heterogeneous group of clonal hematopoietic disorders. MDS is frequently associated with deletions on chromosome 5q as well as aberrant DNA methylation patterns including hypermethylation of key tumor suppressors. We have previously shown that hypermethylation and silencing of the non-coding RNA VTRNA2-1 are correlated with poor outcomes in acute myeloid leukemia patients. In this study, we find that VTRNA1-2 and VTRNA1-3, both located on chromosome 5q, can be regulated and silenced by promoter DNA methylation, and that the hypomethylating agent 5-aza-2-deoxycytidine causes reactivation these genes. In normal hematopoiesis, we find that vault RNAs (vtRNAs) show differential methylation between various hematopoietic cell populations, indicating that allele-specific methylation events may occur during hematopoiesis. In addition, we show that VTRNA1-3 promoter hypermethylation is frequent in lower risk MDS patients and is associated with a decreased overall survival.
30
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text
Pierre Fenaux, Ghulam J. Mufti, Eva Hellström‐Lindberg et al. · The Lancet Oncology · 2009 · 2.6K citations · Full text
David Roulois, Helen Loo Yau, Rajat Singhania et al. · Cell · 2015 · 1.5K citations · Full text
Decitabine improves patient outcomes in myelodysplastic syndromes
Hagop M. Kantarjian, Jean‐Pierre J. Issa, C Rosenfeld et al. · Cancer · 2006 · 1.5K citations
Medicine, Hematology, Pharmacology +14